Jul. 27, 2022
EZM0414
oral SETD2 Inhibitor Ph. I candidate in oncology in-house library screening and SBDD ACS Med. Chem. Lett. Epizyme Inc., Cambridge, MA
oral SETD2 Inhibitor Ph. I candidate in oncology in-house library screening and SBDD ACS Med. Chem. Lett. Epizyme Inc., Cambridge, MA